Home  >  Products  >  TCL1A (T-cell leukemia/lymphoma 1A) Blocking Peptide (the N terminal of protein) (100ug)
TCL1A (T-cell leukemia/lymphoma 1A) Blocking Peptide (the N terminal of protein) (100ug)

TCL1A (T-cell leukemia/lymphoma 1A) Blocking Peptide (the N terminal of protein) (100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-TCL1A antibody (Catalogue #: ARP58808_P050) made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Presku: AAP58808
Size: 100 ug
Weight: 13kDa
Gene: 8115
Format: Lyophilized powder
Target: TCL1A can enhance the phosphorylation and activation of AKT1, AKT2 and AKT3;promote nuclear translocation of AKT1;enhance cell proliferation, stabilize mitochondrial membrane potential and promote cell survival.
Alternative names: TCL1
See Full Product Listings >